Richard Nix, MD
Orthopaedic Surgery · Little Rock, ARNPI 1295727154
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,738 of the $8,198 with a category attached, or 70.0%. Stryker accounts for 93.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $2,181 and has fallen 78.0% since, to $480 in 2025.
Across 190 payments — averaging $43.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Amgen$131
- Zimmer Biomet$102
- Bioventus LLC$52
- Smith+Nephew$47
- Misonix Inc$42
- plus $166 from 8 others
What the payments were for
- Speaking & faculty fees$210%
- Travel & lodging$2,43930%
- Food & beverage$5,73870%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 165 | $7,659 |
| Amgen(2 entities) | 8 | $131 |
| Zimmer Biomet | 1 | $102 |
| Bioventus LLC | 2 | $52 |
| Smith+Nephew | 3 | $47 |
| Misonix Inc | 1 | $42 |
| KCI USA, Inc. | 1 | $30 |
| Sanara Medtech Inc. | 1 | $27 |
| Heron Therapeutics, Inc. | 1 | $24 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Solventum Corporation | 1 | $19 |
| Heraeus Medical, LLC. | 3 | $17 |
| Integra Lifesciences Corporation | 1 | $16 |
| Radius Health, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,198 in reported general payments places this provider in the 75th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $10,880 |
| Diclofenac Sodium | 481 | $5,017 |
| Etodolac | 88 | $2,257 |
| Celecoxib | 111 | $1,932 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 178 | $1,407 |
| Prednisone | 146 | $1,004 |
| Sulindac | 88 | $813 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $493 |
| Cephalexin | 206 | $474 |
| Tramadol Hcl | 39 | $88 |
| Gabapentin | 12 | $88 |
| Meloxicam | 28 | $73 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $42 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Little Rock
- Benjamin StronachLittle Rock$2.5M
- Charles BarnesLittle Rock$2.1M
- Kenneth MartinLittle Rock$322K
- David BumpassLittle Rock$175K
- Lawrence O'MalleyLittle Rock$151K
- Jason SmithLittle Rock$102K
- Richard McCarthyLittle Rock$75K
- Jacob TauntonLittle Rock$62K
- Jeffrey ReeseLittle Rock$59K
- Justin RabinowitzLittle Rock$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.